Neovasc Receives FDA Approval to Initiate Pivotal Reducer Trial
6 November 2017
Neovasc Inc. announced that it has received approval of the U.S. Food and Drug Administration ("FDA") to initiate the COSIRA-II IDE pivotal clinical trial. The trial's purpose w